|
|
|
|
|
|
|
|
|
|
|
|
|
H.B. 1287
|
|
VETOES
|
|
|
|
|
|
|
|
|
|
(II) ONE OF WHOM REPRESENTS THE PERSPECTIVE OF HOSPITAL
OUTPATIENT PHARMACIES;
(8) (9) A FEDERAL LAW ENFORCEMENT OFFICIAL, APPOINTED BY THE
SECRETARY AFTER CONSULTATION WITH THE DRUG ENFORCEMENT
ADMINISTRATION OF THE UNITED STATES DEPARTMENT OF JUSTICE;
(9) (10) A STATE LAW ENFORCEMENT OFFICIAL, APPOINTED BY THE
SECRETARY AFTER CONSULTATION WITH THE MARYLAND STATE POLICE;
(10) (11) A LOCAL LAW ENFORCEMENT OFFICIAL, APPOINTED BY THE
SECRETARY AFTER CONSULTATION WITH THE MARYLAND CHIEFS OF POLICE
ASSOCIATION;
(11) (12) A PROSECUTOR, APPOINTED BY THE SECRETARY AFTER
CONSULTATION WITH THE MARYLAND STATE'S ATTORNEYS ASSOCIATION; AND
(12) (13) TWO MARYLAND CITIZENS WHO REPRESENT THE PERSPECTIVE
OF PAIN PATIENTS, APPOINTED BY THE SECRETARY FROM A LIST SUBMITTED BY THE
MARYLAND PAIN INITIATIVE.
(C) THE SECRETARY SHALL DESIGNATE THE CHAIR OF THE BOARD.
(D) (1) THE TERM OF A MEMBER APPOINTED BY THE SECRETARY IS 3 YEARS.
(2) IF A VACANCY OCCURS DURING THE TERM OF AN APPOINTED
MEMBER, THE SECRETARY SHALL APPOINT A SUCCESSOR WHO SHALL SERVE UNTIL
THE TERM EXPIRES.
(E) THE BOARD SHALL:
(1) MEET NOT FEWER THAN THREE TIMES ANNUALLY;
(2) MAKE RECOMMENDATIONS TO THE SECRETARY REGARDING THE
DESIGN AND IMPLEMENTATION OF A PRESCRIPTION MONITORING PROGRAM, IN
ACCORDANCE WITH THE PROVISIONS OF THIS SUBTITLE, INCLUDING
RECOMMENDATIONS ABOUT:
(I) REGULATIONS AND THE NEED FOR ANY FURTHER
LEGISLATION CONCERNING THE PROGRAM; AND
(II) SOURCES OF FUNDING, INCLUDING GRANT FUNDS UNDER THE
HAROLD ROGERS PRESCRIPTION DRUG MONITORING PROGRAM AND OTHER
SOURCES OF FEDERAL, PRIVATE, OR STATE PROGRAMS FUNDS;
(3) (I) PROVIDE WITHIN 180 DAYS AFTER ITS FIRST MEETING, IN
ACCORDANCE WITH § 2-1246 OF THE STATE GOVERNMENT ARTICLE, AN INTERIM
REPORT TO THE GENERAL ASSEMBLY SETTING FORTH THE BOARD'S ANALYSIS AND
RECOMMENDATIONS UNDER ITEM (2) OF THIS SUBSECTION REGARDING THE
DESIGN, IMPLEMENTATION, AND FUNDING OF THE PROGRAM; AND
(II) PROVIDE ANNUALLY TO THE GOVERNOR AND, IN ACCORDANCE
WITH § 2-1246 OF THE STATE GOVERNMENT ARTICLE, THE GENERAL ASSEMBLY AN
ANALYSIS OF THE IMPACT OF THE PROGRAM ON PATIENT ACCESS TO
- 3826 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|